Sun Pharmaceutical

About

Sun Pharmaceutical Industries is India's largest pharmaceutical company and the world's fourth-largest specialty generics manufacturer, founded in 1983 by Dilip Shanghvi. Headquartered in Mumbai, Sun Pharma's portfolio spans branded generics in India (Ranbaxy became part of Sun in 2015 in a landmark $4 billion deal), a large US business, global specialty products (Ilumya for psoriasis, Cequa for dry eye, Odomzo), and a manufacturing footprint spanning 40+ facilities across six continents. The company's dermatology, ophthalmology, and oncology franchises are among the largest in emerging markets, and its Halol, Gujarat plant is one of the most-inspected Indian manufacturing sites by the US FDA.

Projects

• Sun Pharma Ilumya — Global Specialty Growth

  campaign